SCHEMBL4189729

SCHEMBL4189729

CC(C)(C)N(C(=O)O)c1ccccc1NC(=O)c1ccc2c(c1)CCC2NCCc1c[nH]c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ACHE P22303 3/20 0.42
CDK4 P11802 3/20 0.42
CCND1 P24385 3/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
OPRM1 P35372 2/20 0.40
OPRL1 P41146 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
CDK2 P24941 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
NAMPT P43490 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5319934 0.87 MEN1 (0.40) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL4180696 0.86 MEN1 (0.48) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL13653096 0.84 MEN1 (0.43) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL4178795 0.84 HDAC1 (0.55) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL28770269 0.82 MAPT (0.43) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL4184975 0.81 MEN1 (0.54) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL4193510 0.77 HDAC1 (0.46) MEN1KMT2AALDH1A1SMN1; SMN2CDK4
SCHEMBL13653089 0.76 MEN1 (0.47) MEN1KMT2AALDH1A1MAPK1SMN1; SMN2
SCHEMBL4183216 0.76 HDAC1 (0.46) ACHECDK4CCND1NPC1RAB9A
SCHEMBL4183294 0.76 ACHE (0.48) MEN1KMT2AMAPK1ACHENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247590-A1 Indane amides MKI67, PPIP5K2, CCNA1 MEN1 612/4885KMT2A 1662/4885ALDH1A1 1080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.